Key points are not available for this paper at this time.
and human studies. The ineffectiveness of these drugs targeting IL-18 may be largely due to the loophole caused by the involvement of other cytokines and proteins in the signaling pathway of many inflammatory diseases besides the involvement of IL-18. Combination drug therapies, that focus on IL-18 inhibition, in addition to other cytokines, are highly recommended to be considered as an important area of research that needs to be explored.
Building similarity graph...
Analyzing shared references across papers
Loading...
Stella Amarachi Ihim
Gifu University
Sharafudeen Dahiru Abubakar
Memorial Sloan Kettering Cancer Center
Zeineb Zian
Abdelmalek Essaâdi University
Frontiers in Immunology
Harvard University
Brigham and Women's Hospital
Tokyo University of Science
Building similarity graph...
Analyzing shared references across papers
Loading...
Ihim et al. (Thu,) studied this question.
synapsesocial.com/papers/69fc2d9eac6507b361fa3abb — DOI: https://doi.org/10.3389/fimmu.2022.919973